Future clinical studies utilizing RNA‐seq, whole‐genome sequencing, and functional experiments will help clarify the precise incidence, clinical implications, and biological significance of the co‐amplification of MYC and PVT1 in DLBCL. The gene discussed is PVT1; the disease is diffuse large B-cell lymphoma.